Journal
CIRCULATION RESEARCH
Volume 122, Issue 8, Pages 1135-1150Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCRESAHA.118.311912
Keywords
cardiovascular disease; extracellular matrix; insulin resistance; metabolic syndrome; obesity
Funding
- National Institutes of Health [HL125426, DK054902, DK050277, DK059637, DK108159, HL128983, HL132320, DK081572]
- American Heart Association [17SFRN33520059]
Ask authors/readers for more resources
The frequency of prediabetes is increasing as the prevalence of obesity rises worldwide. In prediabetes, hyperglycemia, insulin resistance, and inflammation and metabolic derangements associated with concomitant obesity cause endothelial vasodilator and fibrinolytic dysfunction, leading to increased risk of cardiovascular and renal disease. Importantly, the microvasculature affects insulin sensitivity by affecting the delivery of insulin and glucose to skeletal muscle; thus, endothelial dysfunction and extracellular matrix remodeling promote the progression from prediabetes to diabetes mellitus. Weight loss is the mainstay of treatment in prediabetes, but therapies that improved endothelial function and vasodilation may not only prevent cardiovascular disease but also slow progression to diabetes mellitus.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available